Restoring Insulin Secretion Adult Medication Study

Trial Profile

Restoring Insulin Secretion Adult Medication Study

Phase of Trial: Phase III

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Insulin glargine (Primary) ; Liraglutide (Primary) ; Metformin (Primary)
  • Indications Prediabetic-state; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms RISE Adult
  • Most Recent Events

    • 04 Apr 2016 Planned End Date changed from 1 Dec 2017 to 1 Mar 2019 as reported by record.
    • 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by
    • 07 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top